Nissan Medical Industries Ltd (TLV: NISA)
Israel
· Delayed Price · Currency is ILS · Price in ILA1,285.00
-23.00 (-1.76%)
Dec 22, 2024, 3:49 PM IDT
Nissan Medical Industries Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 19.02 | 5.65 | -36.05 | 36.01 | 56.85 | 15.71 | Upgrade
|
| Depreciation & Amortization | 30.06 | 31.14 | 28.65 | 25.6 | 27.42 | 28.69 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0 | 0.15 | -0.04 | 0.07 | -0.08 | -0.07 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 23.79 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.05 | -0.01 | 0.05 | -5.39 | -0.68 | -0.74 | Upgrade
|
| Loss (Gain) on Equity Investments | 3.51 | 7.06 | 0.64 | -4.62 | -10.66 | -3.64 | Upgrade
|
| Stock-Based Compensation | 1.41 | 0.58 | 0.27 | 1.45 | 3.03 | 0.7 | Upgrade
|
| Other Operating Activities | 29.04 | 34.13 | 3.61 | 25.89 | 52.24 | 20.64 | Upgrade
|
| Change in Accounts Receivable | 22.14 | 33.8 | -19.71 | -16.45 | -21.89 | 3.27 | Upgrade
|
| Change in Inventory | -27.45 | -6.07 | 8.41 | -52 | 9.37 | 8.59 | Upgrade
|
| Change in Accounts Payable | -11.11 | -7.41 | 5.29 | 12.21 | 2.02 | -17.26 | Upgrade
|
| Change in Other Net Operating Assets | 4.86 | 6.69 | -3.22 | -4.8 | 4.95 | -0.88 | Upgrade
|
| Operating Cash Flow | 71.43 | 105.72 | 11.67 | 17.98 | 122.57 | 55.01 | Upgrade
|
| Operating Cash Flow Growth | -2.71% | 805.56% | -35.07% | -85.33% | 122.80% | -35.91% | Upgrade
|
| Capital Expenditures | -8.69 | -9.82 | -9.18 | -8.16 | -13.86 | -10.13 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.04 | 0.26 | 0.17 | 0.03 | 0.23 | 0.07 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.16 | -0.36 | -0.51 | -0.14 | -0.05 | -0.08 | Upgrade
|
| Investment in Securities | 10.56 | - | -0.15 | 8.42 | 0.59 | 2.41 | Upgrade
|
| Other Investing Activities | -12.71 | - | - | 5.48 | 0.66 | 0.8 | Upgrade
|
| Investing Cash Flow | -10.96 | -9.93 | -9.68 | 5.62 | -12.42 | -6.92 | Upgrade
|
| Short-Term Debt Issued | - | 6.82 | 13.37 | - | - | 13.11 | Upgrade
|
| Long-Term Debt Issued | - | 0.5 | 42.71 | 89.91 | 80.73 | 55.05 | Upgrade
|
| Total Debt Issued | 54.02 | 7.32 | 56.08 | 89.91 | 80.73 | 68.16 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -3.42 | -42.16 | - | Upgrade
|
| Long-Term Debt Repaid | - | -73.67 | -66.82 | -80.87 | -79.12 | -94.49 | Upgrade
|
| Total Debt Repaid | -85.99 | -73.67 | -66.82 | -84.29 | -121.28 | -94.49 | Upgrade
|
| Net Debt Issued (Repaid) | -31.97 | -66.35 | -10.75 | 5.61 | -40.55 | -26.33 | Upgrade
|
| Common Dividends Paid | - | - | -4 | -9.08 | -9.99 | - | Upgrade
|
| Other Financing Activities | -32.06 | -24.36 | -11.04 | -27.73 | -29.72 | -13.26 | Upgrade
|
| Financing Cash Flow | -64.03 | -90.71 | -25.78 | -31.2 | -80.26 | -39.59 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.73 | 0.46 | 3.03 | -0.88 | -2.87 | -1.29 | Upgrade
|
| Net Cash Flow | -4.28 | 5.53 | -20.75 | -8.48 | 27.01 | 7.22 | Upgrade
|
| Free Cash Flow | 62.74 | 95.9 | 2.49 | 9.82 | 108.71 | 44.89 | Upgrade
|
| Free Cash Flow Growth | -5.27% | 3745.07% | -74.60% | -90.97% | 142.19% | -39.32% | Upgrade
|
| Free Cash Flow Margin | 8.72% | 13.07% | 0.36% | 1.47% | 15.07% | 7.41% | Upgrade
|
| Free Cash Flow Per Share | 6.75 | 10.56 | 0.27 | 1.08 | 11.97 | 4.94 | Upgrade
|
| Cash Interest Paid | 14.62 | 16.31 | 11.04 | 10.11 | 10.44 | 12.65 | Upgrade
|
| Cash Income Tax Paid | 7.88 | 9.3 | 2.34 | 11.64 | 7.89 | 3.88 | Upgrade
|
| Levered Free Cash Flow | 46.12 | 54.04 | -4.51 | -1.37 | 73.13 | 27.25 | Upgrade
|
| Unlevered Free Cash Flow | 58.06 | 67.33 | 1.75 | 3.18 | 79 | 35.35 | Upgrade
|
| Change in Net Working Capital | 4.67 | -7.43 | 16.38 | 56.7 | 6.5 | 6.8 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.